Kui Guo

2PUBLICATIONS
3CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Dec 22, 2022
ABX-1431 inhibits the development of endometrial adenocarcinoma and reverses progesterone resistance by targeting MGLL.

Xiaohong Ma, Min Xia, Lina Wei

|May 27, 2021
Fatostatin reverses progesterone resistance by inhibiting the SREBP1-NF-κB pathway in endometrial carcinoma.

Xiaohong Ma, Tianyi Zhao, Hong Yan

Pageof 1

Frequent Collaborators

2 joint publications

Xiaohong Ma

2 joint publications

Chunping Qiu

2 joint publications

Jie Jiang